Roger Neel sold his SaaS company at $100M+ ARR, took three hours off, and dove straight into a health tech startup backed by Google Ventures and Dexcom.
In this conversation, Roger breaks down the full arc — from founding Mavenlink in the teeth of the 2008 financial crash, to grinding through 13 years of customer base churn, fundraising rounds, and eventually selling to PE. He also shares what he'd do completely differently if he were starting today with AI tools at his disposal to build a 9-figure business.
We get into his framework for evaluating whether a business is actually defensible (he calls it the 3 Ds), why most SaaS companies don't need a moat until they're past $10M, what really happens when you sell to a PE firm, and how a regulatory curveball nearly killed his new company Signos right before launch.
Key Takeaways with Roger Neel
(01:48) Building A $100M Company In The AI Era
(04:03) The Origin Story Of Mavenlink
(07:01) The Future Of SaaS And Custom Software
(09:25) The Three Ds: Demand, Differentiation, Defensibility
(17:18) Why He Jumped Into Health Tech
(19:26) Finding Your Actual Passion In Business
(21:51) How Signos Revolutionized Continuous Glucose Monitoring
(27:27) When A Regulatory Shift Breaks Your Model
(33:16) Bootstrapping Vs. Raising Capital
(38:09) The 13-Year Growth Arc To Exit
(41:54) Going Up Market Faster With AI
(46:43) Selling To PE: How The Deal Actually Works
(48:48) Why Keep Raising Instead Of Selling Earlier
(50:24) PE vs. IPO
(51:02) Picking The Right PE Firm
(58:03) Advice For Raising Capital Today
(59:30) AI Tools Entrepreneurs Should Be Using
Watch on YouTube: https://youtu.be/ktl53U-LLL0
Let's Connect:
Website | Instagram | YouTube | TikTok | Twitter | Facebook
